Literature DB >> 15679739

Evidence of desloratadine syrup efficacy and tolerability in children with pollen-induced allergic rhinitis.

G A Rossi1, M A Tosca, G Passalacqua, B Bianchi, C Le Grazie, G W Canonica.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15679739     DOI: 10.1111/j.1398-9995.2005.00714.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  5 in total

1.  Update on prescription and over-the-counter histamine inverse agonists in rhinitis therapy.

Authors:  Lawrence DuBuske; Krzysztof Kowal
Journal:  Curr Allergy Asthma Rep       Date:  2009-03       Impact factor: 4.806

2.  Desloratadine dose selection in children aged 6 months to 2 years: comparison of population pharmacokinetics between children and adults.

Authors:  Samir K Gupta; Bhavna Kantesaria; Christopher Banfield; Zaiqi Wang
Journal:  Br J Clin Pharmacol       Date:  2007-02-23       Impact factor: 4.335

3.  Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast.

Authors:  Hanna Phan; Matthew L Moeller; Milap C Nahata
Journal:  Drugs       Date:  2009       Impact factor: 9.546

4.  Pharmacokinetics of desloratadine in children between 2 and 11 years of age.

Authors:  Samir Gupta; Sauzanne Khalilieh; Bhavna Kantesaria; Christopher Banfield
Journal:  Br J Clin Pharmacol       Date:  2007-05       Impact factor: 4.335

5.  Desloratadine therapy improves allergic rhinitis symptoms in latin american children aged 6 to 12 years.

Authors:  Paolo Tassinari; Nelson R Suárez; Jorge Centeno; Janina Vergara Velásquez; Héctor Aguirre-Mariscal; Sandra N Gonzálezdíaz; Alfredo Fernández de Córdova Jerves
Journal:  World Allergy Organ J       Date:  2009-04       Impact factor: 4.084

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.